News
Athersys Presents New Data and Advancements in Stem Cell and Drug Development Programs at Annual R&D Day Yahoo/Globe NewsWire
View ArticleAthersys Releases Encouraging Results for Single Dose Arm of MultiStem
Athersys Releases Encouraging Results for Single Dose Arm of MultiStem Seeking Alpha
View ArticleAthersys receives orphan drug designation for MultiStem
Athersys receives orphan drug designation for MultiStem The Fly on the Wall
View ArticleAthersys' MultiStem Platform Tempts Big Pharma And Investors
Athersys' MultiStem Platform Tempts Big Pharma And Investors Seeking Alpha
View ArticleAthersys, Inc.: Clinical Trial For Inflammatory Bowel Disease
Athersys, Inc.: Clinical Trial For Inflammatory Bowel Disease Seeking Alpha
View ArticleAthersys: A Potential Stroke Therapy Monopoly On Hand
Athersys: A Potential Stroke Therapy Monopoly On Hand Seeking Alpha
View ArticleAthersys: Remarkable Treatment For Ischemic Stroke Feasibly On The Way
Athersys: Remarkable Treatment For Ischemic Stroke Feasibly On The Way Seeking Alpha
View ArticleAthersys: Two Crucial Near-Term Events
Athersys: Two Crucial Near-Term Events Seeking Alpha
View Article2 Cell Therapy Companies That Could Thrive With Cardiovascular Disease...
2 Cell Therapy Companies That Could Thrive With Cardiovascular Disease Treatments Seeking Alpha
View Article3 Biotechs Expecting Top Line Phase 2 Data Mid 2014
3 Biotechs Expecting Top Line Phase 2 Data Mid 2014 Seeking Alpha
View ArticleAthersys stem-cell therapy for bowel disease fails in study
Athersys stem-cell therapy for bowel disease fails in study Yahoo/Reuters
View ArticleThe Biggest Biotech Catastrophes of the Week
The Biggest Biotech Catastrophes of the Week Motley Fool
View Article
